With extensive experience in private equity, the fund manager has successfully executed over 25 deals, primarily focusing on technology and healthcare sectors across North America and Europe. Emphasizing a data-driven approach, they have cultivated a diverse portfolio that includes notable exits in the biotech space. Their strategic style leans towards operator-first investments, ensuring strong operational oversight and long-term value creation. This expertise in early to growth-stage investments underscores a commitment to identifying high-potential opportunities within dynamic industries.